SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The LAPTOP.X token is trending following a massive price collapse shortly after its launch, which the community is widely characterizing as a significant rug pull. Traders are debating the legitimacy of the project, with many expressing skepticism toward political-themed meme coins and frustration over the rapid devaluation of their holdings.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie shares are trending following the company's agreement to acquire Apogee Therapeutics for $10.9 billion to bolster its immunology and asthma pipeline. While investors monitor the impact of this large acquisition on future earnings, the stock is also receiving attention as part of a broader rotation into defensive healthcare assets.

Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its products include Palldyne IQ and Palladyne Pilot. The company was founded by Fraser M. Smith and Benjamin G. Wolff in 2015 and is headquartered in Salt Lake City, UT.

Palladyne AI Corp.

The community is focused on the company's recent strategic partnerships and ongoing validation of its SwarmOS software through U.S. military exercises and defense contracts. While some traders express frustration with price performance and dilution concerns, many are accumulating shares, anticipating that continued contract wins and long-term autonomy technology trends will drive significant valuation growth.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera is experiencing high volatility and negative sentiment as investors express frustration over its prolonged price decline, with many debating the impact of upcoming legislative developments like the Clarity Act. While some traders are bearish and critical of the token's performance, others are using the current dip as a long-term accumulation opportunity, citing HBAR's ongoing institutional partnerships and infrastructure developments.

Uranium Energy Corp. engages in the provision of uranium and titanium mining and related activities, including exploration, pre-extraction, extraction, and processing of uranium concentrates, and titanium minerals. It operates through the following geographical segments: Wyoming, Texas, Saskatchewan, and Others. The company was founded by Alan P. Lindsay and Amir Adnani on May 16, 2003 and is headquartered in Corpus Christi, TX.

Uranium Energy Corp

The conversation surrounding Uranium Energy Corp. is largely driven by its position as a domestic, unhedged producer within the context of the growing nuclear energy sector. Traders are debating the stock's recent performance, with some expressing frustration over technical price action and recent volatility, while others emphasize its long-term potential as a critical component of the U.S. nuclear energy infrastructure.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is experiencing downward price pressure as investors react to news of a salmonella outbreak linked to jalapeños within its supply chain, though many traders view the sell-off as an overreaction and a potential buying opportunity. While some community members express concern over the health scare and potential impact on food safety reputation, others highlight the company's proactive removal of the ingredient and its strong long-term fundamentals as reasons to accumulate shares.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as traders focus on the company's role in the domestic critical minerals supply chain, bolstered by positive quarterly financial results and significant government support, including DoD partnerships and price floor commitments. Community sentiment is largely bullish, with investors highlighting the strategic importance of U.S.-based magnet production amidst ongoing trade tensions and potential supply chain disruptions with China.

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Zoetis Inc - Ordinary Shares - Class A

Zoetis is trending as traders react to positive updates regarding a conditional USDA license for its avian influenza vaccine, fueling optimism about long-term growth and potential market expansion. While some investors remain cautious due to ongoing competitive pressures and sector-wide volatility, many are viewing the current price as a buying opportunity, emphasizing the company's strong fundamentals and innovative product pipeline.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is experiencing negative sentiment following Q1 financial results that showed revenue missing analyst expectations and continued high R&D spending, despite the company's expanding global footprint and robotaxi partnerships.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is trending as investors monitor its pipeline development and long-term strategy to address upcoming patent cliffs for major drugs. Community discussion remains focused on its strategic M&A potential, AI-driven drug discovery partnerships, and the competitive landscape for its key oncology portfolio.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of BioLife Solutions, Inc. (NasdaqCM: BLFS) to Repligen Corporation (NasdaqGS: RGEN). Under the terms of the proposed transaction, shareholders of...

Roche Gets FDA Priority Tag for Enspryng in Rare Autoimmune Disorder

RHHBY's sBLA for Enspryng wins FDA priority tag for myelin oligodendrocyte glycoprotein antibody-associated disease. A decision is due on Jan. 10, 2027.

Novartis' Del-desiran Fails Late-Stage DM1 Study, Shares Fall

NVS' del-desiran fails the HARBOR study's primary endpoint, adding to recent pipeline setbacks as investors await next steps.

FDA Accepts & Gives Priority Review to Intellia's BLA for HAE Drug

NTLA's BLA for lonvo-z wins FDA priority review for the treatment of HAE. A decision from the agency is expected by March 10, 2027.

ABBV's Etentamig Meets Goals in Phase III Multiple Myeloma Study

AbbVie's etentamig meets key phase III goals in multiple myeloma, improving response rates and progression-free survival versus standard therapies.

Why Is ImmunityBio (IBRX) Up 9.7% Since Last Earnings Report?

ImmunityBio (IBRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

TEVA's TEV '408 Meets Goal in Phase IIa Celiac Disease Study

Teva's TEV '408 meets its phase IIa celiac disease goal, preventing gluten-induced intestinal damage and showing a favorable safety profile.

QURE Submits Application for Gene Therapy for Huntington's Disease

QURE seeks accelerated FDA approval for AMT-130, with Priority Review and a U.K. filing adding momentum to its regulatory push.

Novartis' Remibrutinib Delivers Positive Results in Late-Stage MS Studies

Novartis' remibrutinib delivers positive phase III RMS results, reducing relapse rates versus Aubagio and supporting plans for global regulatory approvals.

Why Is Jazz (JAZZ) Down 6.9% Since Last Earnings Report?

Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Repligen Corp.

These Two Biotech Stocks Recorded Fresh Milestones Today – What’s Driving Today’s Gains?

Equity

Neutral Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Current Price	$165.18
Prev Close	$164.68
Open	$166.72
Dividend Yield	0.00%
50-Day Moving Average	$157.71
Beta	1.43
Avg. Volume	987,228.76
PE Ratio	225.13

52-Week High	$188.73
52-Week Low	$100.99
Market Capitalization	$9.32B
EPS (Annual)	$0.8644
Price to Book	4.41
Revenue Per Employee	$369,128.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

RGEN Fundamentals